The OCT SORT-OUT VIII Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 160 participants.

Also called NCT02253108

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02253108
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02253108. Randomized; no masking; primary purpose treatment. Start 2014-05 (actual); primary completion 2015-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The OCT SORT-OUT VIII Study
Acronym
OCT SORT-OUT
Condition
Angina Pectoris
Intervention (Device)
Everolimus eluting bioresorbable polymer stent
Intervention (Device)
Biolimus eluting bioresorbable polymer stent
Lead sponsor
Aarhus University Hospital Skejby (class: other)
Collaborator
Biosensors International (class: other)
Collaborator
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct02253108
Content hash
b7a53abc341799360fd52078236892ae8e87410e19e01443c4f89add1680b15f